We have a new name, fit for a warrior. PsiOxus Therapeutics is now Akamis Bio! Today we also announced a $30M convertible note financing led by ARCH Venture Partners, @parkerici & @BioWestlake that will further leverage our T-SIGn® tumor #genetherapy platform. #solidtumors